The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma

The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma

ABSTRACT Objective: Although the prognostic role of BRAFV600E mutation in papillary thyroid carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the mutational status in their risk stratification system. To evaluate the impact of the BRAFV600E mutation status on PTC ris...

Full description

Bibliographic Details
Main Authors: Rafael Selbach Scheffel, Ana Patrícia de Cristo, Mirian Romitti, Carla Vaz Ferreira Vargas, Lucieli Ceolin, André B. Zanella, Jose Miguel Dora, Ana Luiza Maia
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2020-08-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Papillary thyroid carcinoma
BRAF mutation
risk classification
persistent disease
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600751&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600751&tlng=en

Similar Items